A new report published online in the Journal of the American Medical Association suggests that taking a transplant may be as safe and effective as waiting for a kidney, even though kidney transplants have not yet been fully proven.
“This study demonstrates that, while kidney transplanted individuals are not 100% free of adverse events, they can still receive a complete life-long recovery and full-spectrum anti-rejection treatment,” the authors wrote.
The authors, led by Mark M. Waddell, professor of epidemiology at the University of Texas Health Science Center at Houston, found that the risk of serious adverse events associated with transplantation was significantly lower than that of non-transplant recipients.
The study also noted that the study is limited because there were no data on how long transplant recipients had been waiting for their kidneys.
While there is limited data on transplant recipients’ outcomes following transplantation, the authors said, “there is good evidence that transplantation does not increase the risk for mortality following kidney transplantation.”
A kidney transplant is a life-saving procedure that is done to help patients living with chronic kidney disease.
In recent years, more and more transplants are being performed, including a kidney from a deceased donor and a heart transplant from a living donor.
In all, more than 100,000 kidney transplans have been performed since 2000, according to the U.S. Department of Health and Human Services.
But kidney transplant recipients who receive a transplant are still at risk for a number of health issues, including complications, infections and deaths.
There are a number factors that can contribute to kidney failure and death, and the potential for complications from transplantation is not fully understood.
In a recent study published in the journal JAMA, researchers found that kidney transplant rejection is more common among transplants from living donors, and there is also an increased risk of infection.
“Although these complications are relatively rare, they are the most frequent complication associated with kidney transplantations,” said lead author Mireille Bagnall, a research associate at the Johns Hopkins University School of Medicine.
“The majority of the cases of infection associated with transplants do not involve the kidneys themselves, but are the result of the infection itself.”
A recent study, which looked at the relationship between donor and recipient organ function, found an increased chance of infection in transplant recipients.
This increased risk could result from the fact that donors are older and have been living longer.
A recent review of transplant-related complications found that in patients with kidney failure, an average of five people die annually.
“Given the limited data available on transplant-associated complications, the outcomes for kidney transplant patients should be viewed with great caution,” the report said.
The researchers noted that transplant patients who received a transplant from an organ donor or a living recipient had higher rates of infection than transplant recipients with kidney disease alone.
There were also significant differences between transplant recipients and transplant recipients without kidney disease and transplant recipient without kidney failure.
For example, transplant recipients were more likely to be living with HIV and were more often hospitalized for complications.
“There is a greater risk of organ rejection in transplant patients with transplant-based renal disease,” the researchers wrote.
“In addition, there is a higher risk of infections with viral infections that are transmitted from donors to recipients, which may have a direct effect on the outcomes of transplant recipients.”
Follow Stephanie Pappas on Twitter at @sipappas or call her at 410-824-2409.